Zacks Research Issues Positive Estimate for DLB Earnings

Dolby Laboratories, Inc. (NYSE:DLB) – Research analysts at Zacks Research increased their Q2 2025 earnings per share estimates for shares of Dolby Laboratories in a note issued to investors on Wednesday, February 19th. Zacks Research analyst R. Department now expects that the electronics maker will earn $1.05 per share for the quarter, up from their previous estimate of $1.04. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.94 per share. Zacks Research also issued estimates for Dolby Laboratories’ FY2025 earnings at $2.97 EPS, Q1 2026 earnings at $0.80 EPS, Q2 2026 earnings at $0.86 EPS, Q4 2026 earnings at $0.74 EPS, FY2026 earnings at $3.05 EPS and FY2027 earnings at $3.25 EPS.

A number of other brokerages also recently issued reports on DLB. Barrington Research reiterated an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a report on Thursday, February 13th. Rosenblatt Securities reiterated a “buy” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Thursday, January 30th. Finally, StockNews.com lowered shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research report on Friday, January 31st.

Dolby Laboratories Price Performance

Shares of Dolby Laboratories stock opened at $81.34 on Monday. The stock has a market cap of $7.76 billion, a price-to-earnings ratio of 29.90 and a beta of 0.98. The firm’s 50-day moving average is $80.68 and its two-hundred day moving average is $76.44. Dolby Laboratories has a 1 year low of $66.35 and a 1 year high of $89.66.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 19th. Shareholders of record on Tuesday, February 11th were paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date of this dividend was Tuesday, February 11th. Dolby Laboratories’s dividend payout ratio (DPR) is presently 48.53%.

Insider Buying and Selling

In related news, CMO Todd Pendleton sold 18,121 shares of the business’s stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $83.75, for a total transaction of $1,517,633.75. Following the completion of the transaction, the chief marketing officer now directly owns 37,290 shares in the company, valued at $3,123,037.50. The trade was a 32.70 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Mark Andrew Sherman sold 40,000 shares of Dolby Laboratories stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $84.88, for a total transaction of $3,395,200.00. Following the transaction, the executive vice president now directly owns 62,397 shares of the company’s stock, valued at approximately $5,296,257.36. This trade represents a 39.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 77,459 shares of company stock worth $6,464,675 in the last three months. Corporate insiders own 38.39% of the company’s stock.

Institutional Trading of Dolby Laboratories

A number of hedge funds have recently bought and sold shares of DLB. Bank of New York Mellon Corp grew its holdings in Dolby Laboratories by 64.2% in the 4th quarter. Bank of New York Mellon Corp now owns 4,826,477 shares of the electronics maker’s stock valued at $376,948,000 after buying an additional 1,887,518 shares in the last quarter. Norges Bank purchased a new stake in shares of Dolby Laboratories in the fourth quarter valued at about $55,356,000. Alyeska Investment Group L.P. purchased a new stake in shares of Dolby Laboratories in the fourth quarter valued at about $27,314,000. Frontier Capital Management Co. LLC purchased a new position in Dolby Laboratories during the fourth quarter worth about $24,323,000. Finally, Clifford Capital Partners LLC boosted its holdings in Dolby Laboratories by 3,114.7% in the 3rd quarter. Clifford Capital Partners LLC now owns 270,579 shares of the electronics maker’s stock valued at $20,707,000 after purchasing an additional 262,162 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.